. 2013 Nov 13;22(4):1042–1049. doi: 10.1002/oby.20663
© 2013 The Authors Obesity published by Wiley Periodicals, Inc. on behalf of The Obesity Society (TOS)
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Figure 1.
Study flow diagram. CANA, canagliflozin; PBO, placebo.